UPDATE — Iterum Therapeutics to Present Data from Phase 3 Trials in Uncomplicated and Complicated Urinary Tract Infections at IDWeek 2020 October 19, 2020 - NASDAQ Companies 0 Bay Street News » View More News for October 19, 2020